Leukocyte/Endothelium Activation and Interactions During Femoral Percutaneous Transluminal Angioplasty

Abstract

Recent data suggest that leukocyte-endothelium activation/interactions are important for restenosis after percutaneous transluminal angioplasty (PTA). Ten patients with superficial femoral artery occlusive disease (stage Fontaine llb) were examined after a percutaneous transluminal angioplasty (PTA) versus a preceding aortoangiography (AAG). Blood samples from corresponding femoral arteries and veins were obtained before, immediately after, and 4 hours after each procedure. The authors examined the ex vivo respiratory burst and leukocytic expression of adhesion molecules flowcytometrically, adhesion molecule plasma concentrations, and inflammatory mediators concentrations in plasma and in endotoxin-stimulated whole blood cultures by ELISA, and the leukocyte counts.

After PTA, venous plasma concentrations of soluble (s)L-selectin (148.2 ± 14.7%, p<0.05 vs 100% baseline ± sem), sP-selectin (130.7 ±6.9%, p<0.01; sE-selectin (117.5 ±8.3%, p<0.05 vs arterial), sLFA-3 (130.7 ±15.8%, p<0.05) were increased. Expressions of L-selectin (93.0 ±5.7%, p<0.05 vs arterial), CD11a (98.8 ±3.8%, p=0.06), CD18 (96.9 ±4.0%, p<0.05 vs arterial), and ICAM-1 (89.1 ±7.7%, p<0.05) on polymorphonuclear neutrophils (PMN), and arteriovenous leukocyte counts (arterial: 103.5 ±5.4%, venous: 91.1 ±3.3%, p<0.05) decreased. Venous ex vivo secretions of oxygen radicals (141.4 ±28.1%, p<0.05 vs AAG), PMN-elastase (173.7 ±35.7%, p<0.05 vs AAG), and interleukin (IL)-8 (226.5 ±56.4%, p<0.001; p<0.0001 vs AAG), as well as PMN-elastase (173.7 ±35.7%, p<0.05 vs AAG) and tumor necrosis factor (TNF)-alpha plasma concentrations (124.1 ±11.9%, p=0.06) rose. Four hours after PTA, a leukocytosis and exhausted TNF-alpha (69.8 ±10.4%, p< 0.05) and IL-8 secretions (72.4 ±4.6%, p<0.01) occurred.

PTA induced local leukocyte-endothelium activations (stronger ex vivo mediator productions) and interactions (decreased venous leukocyte counts, increased plasma concentrations, and decreased leukocytic expression of adhesion molecules) with the release of inflammatory mediators (higher plasma concentrations and exhaustions after 4 hours).

Get full access to this article

View all access options for this article.

References

1. Bauriedel G , Kandolf R , Welsch U , et al: Mechanisms of re-stenosis after angioplasty. Z Kardiol 83(suppl 4):31-41, 1994.

2. Egglin TK , O'Moore PV , Feinstein AR , et al: Complications of peripheral arteriography: A new system to identify patients at increased risk. J Vasc Surg 22:787-794, 1995.

3. Grabowski EF , Head C , Michelson AD : Nonionic contrast media. Procoagulant or clotting innocents? Invest Radiol 28(suppl 5):21-24, 1993.

4. Belch JJF , Shaw JW , Kirk G , et al: The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty. Circulation 95:2027-2031, 1997.

5. Sluiter W , Pietersma A , Lamers JM , et al: Leukocyte adhesion molecules on the vascular endothelium: Their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J Cardiovasc Pharmacol 22(suppl 4):37-44, 1993.

6. Gearing AJH , Newman W : Circulating adhesion molecules in disease. Immunol Today 14:506-512, 1993.

7. Springer TA : Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301-314, 1994.

8. Zimmerman GA , Prescott SM , McIntyre TM : Endothelial cell interactions with granulocytes: Tethering and signaling molecules. Immunol Today 13:93-100, 1992.

9. De Servi S . Mazzone A , Ricevuti G . et al: Granulocyte activation after coronary angioplasty in humans. Circulation 82:140-146, 1990.

10.

10. Feldman LJ , Chollet-Martin S , Himbert D , et al: Modulation of the expression of the granulocyte adhesion molecule, CR3, by percutaneous transluminal coronary angioplasty and contrast media. Invest Radiol 29:313-318, 1994.

11.

11. Kurz RW , Graf B , Gremmel F . et al: Increased serum concentrations of adhesion molecules after coronary angioplasty. Clin Sci Colch 87:627-633, 1994.

12.

12. Neumann FJ , Ott I , Gawaz M , et al: Cardiac release of cytokines and inflammatory mediators in acute myocardial infarction. Circulation 92:748-755, 1995.

13.

13. Ikeda H , Nakayama H , Oda T , et al: Neutrophil activation after percutaneous transluminal coronary angioplasty. Am Heart J 128:1091-1098, 1994.

14.

14. Steg PG , Pasquier C , Huu TP , et al: Evidence for priming and activation of neutrophils early after coronary angioplasty. Eur J Med 2:6-10, 1993.

15.

15. Blann A , Midgley H . Burrows G , et al: Free radicals, antioxidants, and endothelial cell damage after percutaneous transluminal coronary angioplasty. Coron Artery Dis 4:905-910, 1993.

16.

16. Baj Z , Kowalski J . Kantorski J , et al: The effect of short-term myocardial ischemia on the expression of adhesion molecules and the oxidative burst of coronary sinus blood neutrophils. Atherosclerosis 106:159-168, 1994.

17.

17. Macey MG , Jiang XP , Veys P , et al: Expression of functional antigens on neutrophils. Effects of preparation. J Immunol Methods 149:37-42, 1992.

18.

18. Haslett C , Guthrie LA , Kopaniak MM , et al: Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119:101-110, 1985.

19.

19. Dubravec DB , Spriggs DR , Mannick JA , et al: Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. Proc Natl Acad Sci USA 87:6758-6761, 1990.

20.

20. Metinko AP , Kunkel SL , Standiford TJ , et al: Anoxiahyperoxia induces monocyte-derived interleukin-8. J Clin Invest 90:791-798, 1992.

21.

21. Rothe G , Valet G : Measurement of phagosomal hydrogen peroxide production with Dihydrorhodamine 123. In: Handbook of Flow Cytometry Methods, ed. by Robinson JP . Chichester, UK: Wiley and Liss, 1993, pp 155-156.

22.

22. Neumann FJ , Richardt G . Schneider M , et al: Cardiac release of chemoattractants induced by coronary balloon angioplasty. Br Heart J 70:27-34, 1993.

23.

23. Hamblin A , Taylor M , Bernhagen J , et al: A method of preparing blood leucocytes for flow cytometry which prevents upregulation of leucocyte integrins. J Immunol Methods 146:219-228, 1992.

24.

24. Rebuck N , Finn A : Polymorphonuclear granulocyte expression of CD11a/CD18, CD11b/CD18, and L-selectin in normal individuals. FEMS Immunol Med Microbiol 8:189-195, 1994.

25.

25. Berg M , James SP : Human neutrophils release the Leu-8 lymph node homing receptor during cell activation. Blood 76:2381-2388, 1990.

26.

26. O'Brien KD , McDonald TO , Chait A , et al: Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93:672-682, 1996.

27.

27. Deckert M , Kubar J , Bernard A : CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation. J Immunol 148:672-677, 1992.

28.

28. Darbonne WC , Rice GC , Mohler MA , et al: Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 88:1362-1369, 1991.

29.

29. Van Kessel KP , van Strijp JA , Verhoef J : Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils. J Immunol 147:3862-3868, 1991.

30.

30. Cronstein BN , Weissmann G : The adhesion molecules of inflammation. Arthritis Rheumatism 36:147-155, 1993.

31.

31. Entman ML , Smith CW : Postreperfusion inflammation. A model for reaction to injury in cardiovascular disease. Cardiovasc Res 28:1301-1311, 1994.

32.

32. Lund-Johansen F , Terstappen LW : Differential surface expression of cell adhesion molecules during granulocyte maturation. J Leukoc Biol 54:47-55, 1993.

33.

33. Barron MK , Lake RS , Buda AJ , et al: Intimal hyperplasia after balloon injury is attenuated by blocking selectins. Circulation 96:3587-3592, 1997.

34.

34. Rogers C , Edelman ER , Simon DI : A mAb to the β2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci USA 95:10134-10139, 1998.

35.

35. Golino P . Ambrosio G , Ragni M , et al: Inhibition of leukocyte and platelet adhesion reduces neointimal hyperplasia after arterial injury. Thromb Haemost 77:783-784, 1997.

36.

36. Inoue T , Sakai Y , Morooka S , et al: Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 28:1127-1133, 1996.

37.

37. Inoue T . Hoshi K , Yaguchi I , et al: Serum levels of circulating adhesion molecules after coronary angioplasty. Cardiology 91:236-242, 1999.

38.

38. Tsutsui M , Shimokawa H , Tanaka S , et al: Granulocyte activation in restenosis after percutaneous transluminal coronary angioplasty. Jpn Circ J 60:27-34, 1996.

39.

39. Hayashi Si , Watanabe N , Nakazawa K , et al: Roles of P-selectin in inflammation, neointimal formation, and vascular remodelling in balloon-injured rat carotid arteries. Circulation 102:1710-1717, 2000.

40.

40. Feldman LJ , Aguirre L , Ziol M , et al: Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation 101:908-916, 2000.

41.

41. Lefkovits J , Topol EJ : Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention. Prog Cardiovasc Dis 40:141-158, 1997.

42.

42. Gershlick AH , Spriggins D , Davies SW , et al: Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: Results of a randomised placebo-controlled trail. Br Heart J 71:7-15, 1994.

43.

43. Simon DI , Xu H , Ortlepp S , et al: 7E3 monoclonal antibody direct against the platelet glycoprotein IIb/IIIA cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1. Arterioscler Thromb Vasc Biol 17:528-535, 1997.

44.

44. The CAPTURE investigators : Randomised placebocontrolled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study. Lancet 349:1429-1435, 1997.

45.

45. Costa MA , Sabat M , van der Giessen WJ , et al: Late coronary occlusion after intracoronary brachytherapy. Circulation 100:789-792, 1999.